{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:28:28Z","timestamp":1787502508804,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1097\/md.0000000000010318","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T12:57:12Z","timestamp":1522846632000},"page":"e0318","source":"Crossref","is-referenced-by-count":18,"title":["Fenofibrate monotherapy-induced rhabdomyolysis in a patient with hypothyroidism"],"prefix":"10.1097","volume":"97","author":[{"given":"Dawei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-35-20210309","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/mus.10053","article-title":"Rhabdomyolysis: a review","volume":"25","author":"Warren","year":"2002","journal-title":"Muscle Nerve"},{"key":"R2-35-20210309","doi-asserted-by":"crossref","first-page":"ii","DOI":"10.1155\/2010\/537818","article-title":"Rhabdomyolysis-induced acute renal failure following fenofibrate therapy: a case report and literature review","volume":"2010","author":"Danis","year":"2010","journal-title":"Case Rep Med"},{"key":"R3-35-20210309","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.2337\/diacare.26.8.2482","article-title":"Rhabdomyolysis induced by fenofibrate monotherapy","volume":"26","author":"Barker","year":"2003","journal-title":"Diabetes Care"},{"key":"R4-35-20210309","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2165\/00003495-199754040-00007","article-title":"Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia","volume":"54","author":"Adkins","year":"1997","journal-title":"Drugs"},{"key":"R5-35-20210309","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1161\/01.CIR.98.19.2088","article-title":"Mechanism of action of fibrates on lipid and lipoprotein metabolism","volume":"98","author":"Staels","year":"1998","journal-title":"Circulation"},{"key":"R6-35-20210309","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/08860220701573640","article-title":"Acute renal failure secondary to fenofibrate monotherapy-induced rhabdomyolysis","volume":"29","author":"Tahmaz","year":"2007","journal-title":"Ren Fail"},{"key":"R7-35-20210309","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archinte.1988.00380070059015","article-title":"Factors predictive of acute renal failure in rhabdomyolysis","volume":"148","author":"Ward","year":"1988","journal-title":"Arch Intern Med"},{"key":"R8-35-20210309","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejim.2005.11.004","article-title":"Rhabdomyolysis disclosing hypothyroidism","volume":"17","author":"Rabhi","year":"2006","journal-title":"Eur J Intern Med"},{"key":"R9-35-20210309","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1172\/JCI113508","article-title":"Effects of thyroid hormones on skeletal muscle bioenergetics. In vivo phosphorus-31 magnetic resonance spectroscopy study of humans and rats","volume":"81","author":"Argov","year":"1988","journal-title":"J Clin Invest"},{"key":"R10-35-20210309","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/BF03402159","article-title":"Human mitochondrial transcription factor a reduction and mitochondrial dysfunction in Hashimoto's hypothyroid myopathy","volume":"8","author":"Siciliano","year":"2002","journal-title":"Mol Med"},{"key":"R11-35-20210309","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/ndt\/14.4.1047","article-title":"Fenofibrate-induced rhabdomyolysis in two dialysis patients with hypothyroidism","volume":"14","author":"Clouatre","year":"1999","journal-title":"Nephrol Dial Transpl"},{"key":"R12-35-20210309","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.2337\/diacare.26.8.2482","article-title":"Fenofibrate monotherapy induced rhabdomyolysis","volume":"26","author":"Barker","year":"2003","journal-title":"Diabetes Care"},{"key":"R13-35-20210309","first-page":"268","article-title":"Fenofibrate-induced myopathy","volume":"52","author":"Ghosh","year":"2004","journal-title":"Neurol India"},{"key":"R14-35-20210309","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2143\/AC.63.4.2033052","article-title":"A case of rhabdomyolysis and thromboembolic event secondary to fibrate monotherapy","volume":"63","author":"Yildiz","year":"2008","journal-title":"Acta Cardiol"},{"key":"R15-35-20210309","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4103\/0019-5359.48458","article-title":"Fenofibrate monotherapy- induced rhabdomyolysis in a patient with type-2 diabetes","volume":"62","author":"Cetinkaya","year":"2008","journal-title":"Indian J Med Sci"},{"key":"R16-35-20210309","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00228-009-0723-7","article-title":"Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report","volume":"65","author":"Wu","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"R17-35-20210309","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1590\/S0004-27302009000300015","article-title":"Fenofibrate-induced rhabdomyolysis in a patient with chronic kidney disease: an unusual presenting feature of hypothyroidism","volume":"53","author":"Sousa","year":"2009","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"R18-35-20210309","first-page":"849","article-title":"Fenofibrate-induced rhabdomyolysis in a patient with stage 4 chronic renal failure due to diabetes mellitus","volume":"62","author":"Soyoral","year":"2012","journal-title":"J Pak Med Assoc"},{"key":"R19-35-20210309","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4103\/0253-7613.111912","article-title":"A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: a first report","volume":"45","author":"Kiskac","year":"2013","journal-title":"Indian J Pharmacol"},{"key":"R20-35-20210309","first-page":"249","article-title":"Fenofibrate-induced rhabdomyolysis in an adolescent with chronic renal failure and hypothyroidism","volume":"28","author":"Marques","year":"2014","journal-title":"Port J Nephrol Hypert"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000010318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:02:24Z","timestamp":1620946944000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201804060-00035"}},"subtitle":["A rare case report and literature review"],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":20,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000010318","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}